Generex Biotechnology Corp. (GNBT) News Nov 14, 2014, 8:10

New Post Public Reply Private Reply Replies (0) Message Board

Nov 15, 2014 at 12:14 PM

Generex Biotechnology Corp. (GNBT) News Nov 14, 2014, 8:10 p.m.
MarketWatch News on GNBT
Wednesday’s biggest gaining and declining stocks 5:20 p.m. Oct. 20, 2010 - Kate Gibson
Progress on Diabetes, Cancer Treatments 6:04 p.m. Jan. 14, 2010 - Alexander Davis
Sunesis, Generex, Cubist lead drug stocks higher 1:29 p.m. Dec. 14, 2009 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 4:25 p.m. Dec. 9, 2009 - MarketWatch
Drug stocks trend lower; Pfizer, Dynavax gain 2:34 p.m. Dec. 9, 2009 - Val Brickates Kennedy
Thursday's biggest gaining and declining stocks 4:33 p.m. Dec. 3, 2009 - MarketWatch
Endo falls on FDA move; Generex rallies 12:25 p.m. Dec. 3, 2009 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 5:00 p.m. Sept. 11, 2009 - MarketWatch
Thursday's biggest gaining and declining stocks 4:17 p.m. Sept. 10, 2009 - MarketWatch
Dynavax, Generex rocket as drug stocks gain 1:23 p.m. Sept. 10, 2009 - Val Brickates Kennedy
Drug stocks inch lower while broader market gains 2:27 p.m. June 4, 2009 - Val Brickates Kennedy
Vaccine makers get boost from flu scare 12:20 p.m. May 21, 2009 - Val Brickates Kennedy
Pigs will get slaughtered on swine-flu stocks 5:27 p.m. April 30, 2009 - Chuck Jaffe
Shares of antiviral drugmakers rocket on flu news 12:54 p.m. April 27, 2009 - Val Brickates Kennedy
Niche antiviral drugmakers rocket on flu news 9:08 a.m. April 27, 2009 - Val Brickates Kennedy
As diabetes surges, the search for better treatments intensifies 4:33 p.m. Nov. 25, 2008 - Sara Sargent
Generex Bio says share decline linked to Eli Lilly, Novo Nordisk moves 7:20 a.m. March 11, 2008 - Dow Jones
Drug stocks slide; Mannkind, Alkermes fall for second day 3:48 p.m. March 10, 2008 - Val Brickates Kennedy
CORRECTS: Some small-cap stocks may get hit in '08, but not all 6:18 p.m. Jan. 16, 2008 - MarketWatch
The big picture is often misleading on stocks 8:05 a.m. Jan. 16, 2008 - Chuck Jaffe
Loading more headlines...
Advertisement
Other News on GNBT
10-K: GENEREX BIOTECHNOLOGY CORP 3:05 p.m. Oct. 3, 2014 - Edgar Online - (EDG = 10Q, 10K)
With Ebola Looming, When Will The Defense Department Get Around To Generex? 2:22 a.m. Oct. 1, 2014 - Seeking Alpha
10-Q: GENEREX BIOTECHNOLOGY CORP 3:14 p.m. June 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Provectus: Strong Sell, Ties To Paid Stock Promoters, SEC Halt Risk, Price Target $0 9:40 a.m. May 21, 2014 - Seeking Alpha
Provectus: Ties To Paid Stock Promoters, SEC Halt Risk, History Of Shareholder Wipeouts 9:40 a.m. May 21, 2014 - Seeking Alpha
Generex registers convertible shares 3:21 p.m. April 4, 2014 - Seeking Alpha
10-Q: GENEREX BIOTECHNOLOGY CORP 4:03 p.m. March 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Emerging Biotech Takes Aim At Preventing Recurrent Breast Cancer 10:12 a.m. Jan. 21, 2014 - Seeking Alpha
10-Q: GENEREX BIOTECHNOLOGY CORP 4:40 p.m. Dec. 9, 2013 - Edgar Online - (EDG = 10Q, 10K)
Generex: A Stock Suitable Only For Its Officers And Directors Or Carl Icahn 10:08 a.m. Dec. 2, 2013 - Seeking Alpha
10-K: GENEREX BIOTECHNOLOGY CORP 3:39 p.m. Oct. 11, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: GENEREX BIOTECHNOLOGY CORP 4:05 p.m. June 10, 2013 - Edgar Online - (EDG = 10Q, 10K)
Stocks at New Highs, News Lows for 12/3 4:33 a.m. Dec. 3, 2012 - InvestorPlace.com
Weekly CFO Sells Highlight: TDG, GNBT, ADGE, HFC, AMSWA 3:20 p.m. July 2, 2012 - GuruFocus.com
An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA) 6:14 a.m. May 18, 2012 - 247WallSt.com
Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN) 11:00 a.m. May 10, 2012 - 247WallSt.com
Generex Biotechnology Corp. Reports Operating Results (10-Q) 4:47 p.m. Dec. 12, 2011 - GuruFocus.com
Weekly Healthcare Stock Watch 10:01 a.m. Oct. 5, 2011 - Seeking Alpha
Generex Corporate Update: The potential Is there 9:11 a.m. Aug. 4, 2011 - Seeking Alpha
Stocks To Watch This Week: DNDN, MNKD, CLDX 3:35 a.m. June 27, 2011 - Seeking Alpha
Loading more headlines...
Press Releases on GNBT
Generex Announces Presentation at the Society for Immunotherapy of Cancer Demonstrating that Induction of Antibody Response in Patients Receiving the AE37 Breast Cancer Vaccine Correlates with Reduced Relapse 9:30 a.m. Nov. 11, 2014 - PR Newswire - PRF
Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 8:30 a.m. Oct. 27, 2014 - PR Newswire - PRF
Generex / Antigen Express to Participate in 2014 BIO-Europe® Annual International Partnering Conference 8:30 a.m. Oct. 23, 2014 - PR Newswire - PRF
Generex Announces Publication of Ebola Vaccine White Paper by Antigen Express 8:30 a.m. Oct. 21, 2014 - PR Newswire - PRF
Generex Clarifies Utility of Antigen Express Technology for Potential Ebola Vaccine 8:30 a.m. Oct. 7, 2014 - PR Newswire - PRF
Generex Announces Engagement of Dr. Lakshmi P. Kotra for Buccal Insulin Enhancement Project 8:30 a.m. Sept. 30, 2014 - PR Newswire - PRF
Generex Collaborates with University Health Network for Buccal Insulin Project 8:30 a.m. Sept. 22, 2014 - PR Newswire - PRF
Generex / Antigen Express to Participate in BioPharm America™ 2014 8:15 a.m. Sept. 3, 2014 - PR Newswire - PRF
Generex Announces Publication of AE37 Prostate Cancer Vaccine Study 8:30 a.m. Aug. 6, 2014 - PR Newswire - PRF
Generex Announces Interview of Dr. Eric von Hofe, President of Antigen Express, Following Recent Keynote Presentation 8:30 a.m. June 17, 2014 - PR Newswire - PRF
Generex/Antigen Express Announce Interview of MD Anderson's Dr. Elizabeth Mittendorf, Principal Investigator on Company's AE37 Phase IIb Breast Cancer Efficacy Trial 8:30 a.m. June 12, 2014 - PR Newswire - PRF
Generex / Antigen Express to Participate in 2014 BIO International Convention 8:30 a.m. June 10, 2014 - PR Newswire - PRF
Generex Announces Presentation of Primary Efficacy Data & Immunological Response from the Phase II Study of AE37 Cancer Vaccine at ASCO 8:30 a.m. May 20, 2014 - PR Newswire - PRF
Generex Announces Antigen Express AE37 Breast Cancer Vaccine Abstract Presentations at ASCO 2014 Annual Meeting 8:30 a.m. April 23, 2014 - PR Newswire - PRF
Generex Announces $2,075,000 Capital Investment 8:30 a.m. March 27, 2014 - PR Newswire - PRF
Generex/Antigen Express Announces Participation on Panel at Upcoming Cancer Immunotherapeutics Symposium 8:30 a.m. March 26, 2014 - PR Newswire - PRF
Generex Biotechnology Corp. Granted Patents on New HPV and Influenza Vaccines 11:01 a.m. March 12, 2014 - ACCESSWIRE
Generex Subsidiary Antigen Express Receives Patents for Vaccines Targeting HPV Induced Cancers and Influenza 9:30 a.m. March 5, 2014 - PR Newswire - PRF
Generex Announces Publication of Biomarker Studies Related to the Antigen Express Novel Immunotherapeutic AE37 in Prostate Cancer Patients 9:30 a.m. Feb. 27, 2014 - PR Newswire - PRF
Generex/Antigen Express Interview on Clear Channel Business Talk Radio DFW 1190AM by Host Michael Yorba 10:27 a.m. Feb. 12, 2014 - Marketwire
Loading more headlines...

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Independents Finally Center Stage on Election Night

Unprecedented Spotlight on Independent Voters The political landscape is in for a shake-up, folks. Come November 3rd, we're witnessing something that hasn't been done before—an entire Election Night dedicated exclusively to independent voters. It’s high time these folks got the spotlight, considering a whopping 45% of U.S. adults have shunned the extremist seesaw of...

HIMS Lawsuit: Investors Under the Gun Before Deadline

HIMS Investors Find Themselves in Hot Water Well, it looks like the ball's in your court, folks. Hims & Hers Health, Inc. (NYSE: HIMS) has been caught in a whirlwind of legal drama, and if you're holding any $HIMS stock, you've got some decisions to make—and fast. With a looming November 2 deadline to step up in a securities class action, this is one of those...

Artprice Champions Creative Freedom with AI in 2026

AI and the Creative Reawakening As the autumn of 2026 rolls in, publishing circles are buzzing over artificial intelligence's role in artistry. Weekly updates hailing rejection, tolerance, or adaptation of AI in writing stir the pot. Yet, Artprice by Artmarket stands out by anchoring creative freedom and responsibility in the spotlight. Grounded on an initiative launched...

111, Inc. Strategizes with Advisors Amid Proposal Talks

Every time a company's board starts tossing around phrases like "strategic alternatives," you’ve got to pay closer attention. 111, Inc., holding the NASDAQ ticker YI, is one such entity at a crossroads. They've enlisted Houlihan Lokey China Limited as their independent financial advisor and Kirkland & Ellis as their U.S. legal counsel to sift through potential strategic...

American Water's $10K Grant Boosts Student Financial Skills

Financial Literacy: Building Skills for the Future When it comes to prepping kids for the real world, it's not just about packing their backpacks with textbooks and pencils; it's about arming them with the know-how to make smart financial moves. American Water Charitable Foundation's recent $10,000 grant to Junior Achievement of the Heartland is a shining example of the...

Metallium's U.S. Supply Chain Ambitions Hinge on Traxys MOU

Metallium and Traxys Partner to Boost U.S. Critical Metals Out there in Houston, October's cooked up a potential game-changer for U.S. critical metals supply like no one's business. Metallium Limited—those savvy cats juggling ASX and OTC markets—just laid down a non-binding Memorandum of Understanding (MOU) with Traxys North America LLC. The goal? To sharpen up and...

Govee's Retro Holiday Lights: A Festive Nostalgia Trip

Ah, the holidays—they're creeping up like a kid sneaking downstairs for a peek at their gifts. But it's not the gifts under the tree that brighten a room, it's those lights draping the tree itself. Enter Govee, bringing us back to that vintage glow we all remember from our childhoods. They've teamed up with Brady Tolbert, a design whiz who can make a living room look...

Mesirow Expands Retirement Reach with flexPATH Deal

Retirement Industry Shake-Up Here's the scoop: Mesirow's swinging big in the retirement scene with its latest acquisition of flexPATH's plan-level 3(38) business. In the world of outsourced fiduciarity—for thems ain't in the know—that's like bolting a turbocharger to an already darn good engine. Mesirow might just be strapping itself in for a wild ride in this 2026...

Sirha Lyon® 2027: A New Chapter in Foodservice

A Bold Step Forward There's a hearty aroma wafting from Lyon this January, and it's not just from the local gastronomy. Sirha Lyon® is queuing up for its 23rd edition, promising to turn the Foodservice and Hospitality sectors on their heads. Nearly 150,000 square meters of exhibition space packed to the rafters with over 4,300 exhibitors—this ain't your average trade...

Sinopec's Catalyst Conference: Driving Global Innovation

The Role of Catalysts in Modern Industry Swing by any bustling industrial hub, and you're likely to catch talk about catalysts—unsung heroes that make the machinery of modern industry run smoother, faster, and cleaner. Over in Tianjin, China, Sinopec just wrapped up its Second International Catalyst Customer Conference, which is less of a tongue-twister than it sounds....